This analysis revealed an enrichment of SHH pathway genes, including GLI1, GLI2, HHIP, PTCH1, and PTCH2, in SSTs as compared to high-grade serous ovarian cancers and other sex cord-stromal tumors (Fig. 4a). This evidence concerns the gene GLI2 and ovarian serous adenocarcinoma.